Evaluation of a rapid antigen detection test (Panbio™ COVID‐19 Ag Rapid Test Device) as a point‐of‐care diagnostic tool for COVID‐19 in a pediatric emergency department

We evaluated the Panbio™ COVID‐19 Ag Rapid Test Device as a point‐of‐care diagnostic tool for COVID‐19 in 357 patients at a pediatric emergency department. Thirty‐four patients tested positive by reverse transcription polymerase chain reaction, of which 24 were positive by the antigen assay. The sen...

Full description

Saved in:
Bibliographic Details
Published in:Journal of Medical Virology 2021-12, Vol.93 (12), p.6803-6807
Main Authors: Carbonell‐Sahuquillo, Silvia, Lázaro‐Carreño, María I., Camacho, Jorge, Barrés‐Fernández, Ana, Albert, Eliseo, Torres, Ignacio, Bretón‐Martínez, José R., Martínez‐Costa, Cecilia, Navarro, David
Format: Article
Language:English
Subjects:
Antigens
Assaying
clinical sensitivity
COVID-19
emergency department
Emergency medical care
Emergency medical services
field evaluation
Patients
pediatric patients
Pediatrics
Polymerase chain reaction
rapid antigen assay
Respiratory tract
Reverse transcription
SARS‐CoV‐2 RNA viral load
Severe acute respiratory syndrome coronavirus 2
Short Communication
Trauma centers
Virology
Citations: Items that this one cites
Items that cite this one
Online Access:Request full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:We evaluated the Panbio™ COVID‐19 Ag Rapid Test Device as a point‐of‐care diagnostic tool for COVID‐19 in 357 patients at a pediatric emergency department. Thirty‐four patients tested positive by reverse transcription polymerase chain reaction, of which 24 were positive by the antigen assay. The sensitivity and specificity of the assay were 70.5% and 100%, respectively. Highlights The PanBio RAD assay performed well for identifying SARS‐CoV‐2 infected children displaying high viral loads in the upper respiratory tract
ISSN:0146-6615
1096-9071
DOI:10.1002/jmv.27220